Neurocysticercosis: Current knowledge and advances

被引:14
|
作者
Shandera, Wayne X. [1 ]
Kass, Joseph S. [1 ]
机构
[1] Sect Gen Med, Dept Med, Houston, TX 77030 USA
关键词
D O I
10.1007/s11910-006-0046-3
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Neurocysticercosis is the most common cause of acquired seizures worldwide. Most cases of this larval stage infection of the pork tapeworm Taenia solium occur in the developing world, although increasing numbers of cases are being recognized in the United States, particularly among Hispanic immigrants. The ability of the pathogen to persist for years within the host is the subject of immunologic and biochemical investigation. The major presenting symptom is seizures, although symptoms of obstructive hydrocephalus occur if cysts are located near the ventricles or in the subarachnoid spaces. Diagnosis is dependent on clinical, radiologic, and serologic data. Therapy with antiparasitic agents, especially albendazole, is effective in large burden disease or disease within sensitive neuraxis sites (the ventricles, the subarachnoid spaces). When patients with radiologically enhancing disease are given cysticidal therapy, there appears to be a reduction in seizure recurrences. Surgery is indicated for disease in selected anatomic sites. Longterm prevention requires attention to pork husbandry and general sanitation, including the potential use of mass human chemotherapy and porcine vaccination.
引用
收藏
页码:453 / 459
页数:7
相关论文
共 50 条
  • [21] Introduction to the special issue: Current advances in collaboration and knowledge work
    Guerrero, Luis A.
    De Vreede, Gert-Jan
    GROUP DECISION AND NEGOTIATION, 2006, 15 (03) : 195 - 196
  • [22] The molecular genetics of inherited deafness - current knowledge and recent advances
    Hardisty, RE
    Fleming, J
    Steel, KP
    JOURNAL OF LARYNGOLOGY AND OTOLOGY, 1998, 112 (05): : 432 - 437
  • [23] Current knowledge on cyanobacterial biobutanol production: advances, challenges, and prospects
    Das, Meenakshi
    Maiti, Soumen K.
    REVIEWS IN ENVIRONMENTAL SCIENCE AND BIO-TECHNOLOGY, 2022, 21 (02) : 483 - 516
  • [24] Nutritional advances in fetal and neonatal development: Introduction to current knowledge
    Caton, Joel S.
    JOURNAL OF ANIMAL SCIENCE, 2020, 98 : 120 - 120
  • [25] Current approaches to cysticidal drug therapy for neurocysticercosis
    Del Brutto, Oscar H.
    EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2020, 18 (08) : 789 - 798
  • [26] Evaluation of current immunodiagnostic criteria for diagnosis of neurocysticercosis
    Katti, MK
    CLINICAL INFECTIOUS DISEASES, 2003, 37 (03) : 461 - 462
  • [27] Current knowledge of COVID-19: Advances, challenges and future perspectives
    Yuhan Wu
    Zhuobing Peng
    Yongxue Yan
    Jintao Hu
    Yalong Wang
    Xiaoyu Wang
    Ruchao Peng
    Daniel Watterson
    Yi Shi
    生物安全与健康(英文), 2021, 03 (04) : 202 - 209
  • [28] The trophodynamics of marine top predators: Current knowledge, recent advances and challenges
    Young, Jock W.
    Hunt, Brian P. V.
    Cook, Timothee R.
    Llopiz, Joel K.
    Hazen, Elliott L.
    Pethybridge, Heidi R.
    Ceccarelli, Daniela
    Lorrain, Anne
    Olson, Robert J.
    Allain, Valerie
    Menkes, Christophe
    Patterson, Toby
    Nicol, Simon
    Lehodey, Patrick
    Kloser, Rudy J.
    Arrizabalaga, Haritz
    Choy, C. Anela
    DEEP-SEA RESEARCH PART II-TOPICAL STUDIES IN OCEANOGRAPHY, 2015, 113 : 170 - 187
  • [29] The current status of neurocysticercosis in Eastern and Southern Africa
    Mafojane, NA
    Appleton, CC
    Krecek, RC
    Michael, LM
    Willingham, AL
    ACTA TROPICA, 2003, 87 (01) : 25 - 33
  • [30] Environmental Biotechnology: Current Advances, New Knowledge Gaps, and Emerging Issues
    Hesham, Abd El-Latif
    Ralebitso-Senior, T. Komang
    Zhang, Yu
    Li, Qing X.
    BIOMED RESEARCH INTERNATIONAL, 2015, 2015